Dr. Reddy’s Laboratories has announced a board meeting scheduled for January 21, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ending December 31, 2025. Additionally, the company has declared a trading window closure for dealing in the company’s securities from December 25, 2025, to January 23, 2026.
Board Meeting Announcement
Dr. Reddy’s Laboratories will hold a meeting of its Board of Directors on January 21, 2026. The primary agenda of the meeting is to review and approve the company’s unaudited standalone and consolidated financial results for the quarter ending December 31, 2025.
Trading Window Closure
In accordance with regulations regarding insider trading, Dr. Reddy’s Laboratories has announced the closure of its trading window. The trading window will be closed from December 25, 2025, and will remain closed until January 23, 2026. This restriction applies to dealing in the company’s securities during this period.
Source: BSE
